Template:Dgfn2015 So 13:00 Mittagssymposium Nr.2, ..ANCA assoziierte Vaskulitiden

From HOP house of papers
Jump to: navigation, search

Contents

So 13:00 Mittagssymposium Nr.2, ..ANCA assoziierte Vaskulitiden

Update zur Diagnostik ANCA-assoziierter Vaskulitiden

Fleck-M

Journal article, free access
GET 2013. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides Extract PDF direct
Weblink noncommercial {{{c}}}
1990 ARA Claasification Issue 33(8), AR
Journal article, free access
GET 2011. Improved outcome in 445 patients with Wegener s granulomatosis in a German vasculitis center over four decades Extract PDF direct
Journal article, free access
GET 2015. Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort Extract PDF direct
internist 2016 56 41 holle submitted

Aktuelle Leitlinien und Ausblicke zur Therapie ANCA-assoziierter Vaskulitiden mit Rituximab

Haubitz-M

??Brock et al.

Journal article, free access
GET 2009. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis Extract PDF direct
Journal article, free access
GET 2009. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients Extract PDF direct

??Schöhermarck ar 2014??

Journal article, free access
GET 2015. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement Extract PDF direct
??DMW 2014 mossig nicht im pm??

Journal article, free access
GET 2014. Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis Extract PDF direct
Journal article, free access
GET 2013. Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial Extract PDF direct
Journal article, free access
GET 2014. Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitis Extract PDF direct
Journal article, free access
GET 2015. Role of therapeutic plasmapheresis in ANCA-associated vasculitis Extract PDF direct

Journal article, free access
GET 2013. Efficacy of remission-induction regimens for ANCA-associated vasculitis Extract PDF direct
Journal article, free access
GET 2013. Induction regimens for ANCA-Associated Vasculitis Extract PDF direct


Journal article, free access
GET 2015. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids Extract PDF direct

(( This article reviews 9 challenging vasculitis mimickers: fibromuscular dysplasia, calciphylaxis, segmental arterial mediolysis, antiphospholipid syndrome, hypereosinophilic syndrome, lymphomatoid granulomatosis, malignant atrophic papulosis, livedoid vasculopathy, and immunoglobulin G4-related disease.))

??ar 2012 carh cebae?????

Journal article, free access
GET 2012. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis Extract PDF direct

für hopn - scleroderm:

Journal article, free access
GET 2012. Timing of transition between capillaroscopic patterns in systemic sclerosis Extract PDF direct

??ard 2015 yusof??

Aktuelle Daten zur Erhaltungstherapie ANCA-assoziierter Vaskulitiden

de-Groot-K

Journal article, free access
GET 2008. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force Extract PDF direct
Journal article, free access
GET 2007. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis Extract PDF direct
Journal article, free access
GET 2007. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies Extract PDF direct
Journal article, free access
GET 2014. Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis Extract PDF direct
Journal Paper, restricted access
GET 2013. Maintenance of clinical remission in ANCA-associated vasculitis Extract PDF direct
Journal article, free access
GET 2012. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis Extract PDF direct

??rheumatology 2010 despujol??

Journal article, free access
GET 2008. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts Extract PDF direct
Journal Paper, restricted access
GET 2005. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis Extract PDF direct
Journal Paper, restricted access
GET 2003. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study Extract PDF direct
Journal Paper, restricted access
GET 2005. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis Extract PDF direct

??author?j... nejm 2003

Journal article, free access
GET 2014. Granulomatosis with polyangiitis (Wegener s): impact of maintenance therapy duration Extract PDF direct
Journal article, free access
GET 2013. Efficacy of remission-induction regimens for ANCA-associated vasculitis Extract PDF direct
Journal article, free access
GET 2013. Induction regimens for ANCA-Associated Vasculitis Extract PDF direct
Journal Paper, restricted access
GET 2015. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial Extract PDF direct
Journal article, free access
GET 2015. Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis Extract PDF direct

??ar 2014 azar?

Journal article, free access
GET 2014. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis Extract PDF direct
Journal article, free access
GET 2015. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis Extract PDF direct

??yusuf ard 2015 gbt es nicht??

Journal article, free access
GET 2015. Maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: who needs what and for how long? Extract PDF direct
Journal article, free access
GET 2014. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis Extract PDF direct
Journal article, free access
GET 2014. Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy Extract PDF direct

??ndt 2015 kronbille??

??ro 2013 benardi??

Journal article, free access
GET 2015. Understanding the role of rituximab in ANCA GN: regressing toward the mean Extract PDF direct
Journal Paper, restricted access
GET 2014. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener s) Results of a single-center cohort study on 66 patients Extract PDF direct
Personal tools
Namespaces
Variants
Actions
Navigation
Toolbox
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis